Literature DB >> 15182142

Prescriptions and dosages of anti-tuberculosis drugs in the National Tuberculosis Control Programme of Malawi.

A D Harries1, F Gausi, F M Salaniponi.   

Abstract

SETTING: All 44 non-private hospitals in Malawi treating pulmonary tuberculosis (PTB) patients with an oral regimen (0.5RHZE/1.5R3H3Z3E3/6HE).
OBJECTIVES: In new smear-positive PTB patients, to determine whether: 1) numbers of tablets were correctly prescribed according to pre-treatment weights, and 2) medication dosages were adequate, too low or too high.
DESIGN: Retrospective review of TB registers and TB treatment cards for patients registered with new smear-positive PTB between 1 October and 31 December 2001.
RESULTS: Of 1970 patients aged > or = 15 years, 1211 (62%) had treatment cards and pre-treatment weights. Incorrect prescriptions were given to 88 (7%), and many of these received dosages of anti-tuberculosis drugs that were too high or too low. For those receiving correct prescriptions, daily treatment in the initial and continuation phases was generally associated with adequate dosages of drugs. However, in the initial intermittent phase, between 3% and 40% of patients received anti-tuberculosis drug dosages that were too low.
CONCLUSION: A small percentage of patients receive incorrect prescriptions, which can be resolved by training and supervision. In those receiving correct prescriptions, intermittent treatment provides dosages that are sometimes too low. Weight bands for intermittent treatment should be re-examined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15182142

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Changing from single-drug to fixed-dose combinations: experience from Fiji.

Authors:  R Mahadeo; S Gounder; S M Graham
Journal:  Public Health Action       Date:  2014-09-21

Review 2.  Drug utilization review across jurisdictions--a reality or still a distant dream?

Authors:  Lisa K Pulver; Susan E Tett
Journal:  Eur J Clin Pharmacol       Date:  2006-01-10       Impact factor: 2.953

3.  Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection.

Authors:  S M Graham; D J Bell; S Nyirongo; R Hartkoorn; S A Ward; E M Molyneux
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Adequacy of anti-tuberculosis drug prescriptions in Viet Nam.

Authors:  N B Hoa; J M Lauritsen; H L Rieder
Journal:  Public Health Action       Date:  2012-03-21

5.  Evaluation of adherence to national treatment guidelines among tuberculosis patients in three provinces of South Africa.

Authors:  Julia V Ershova; Laura Jean Podewils; Liza E Bronner; Heather G Stockwell; Sicelo S Dlamini; Lerole D Mametja
Journal:  S Afr Med J       Date:  2014-03-26

Review 6.  Prevalence of inappropriate tuberculosis treatment regimens: a systematic review.

Authors:  M W Langendam; M J van der Werf; E Huitric; D Manissero
Journal:  Eur Respir J       Date:  2011-10-17       Impact factor: 16.671

7.  Improved consistency in dosing anti-tuberculosis drugs in Taipei, Taiwan.

Authors:  Chen-Yuan Chiang; Ming-Chih Yu; Hsiu-Chen Shih; Muh-Yong Yen; Yu-Ling Hsu; Shiang-Lin Yang; Tao-Ping Lin; Kuan-Jen Bai
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

8.  An audit of diagnosis and treatment of tuberculosis in Ethiopia.

Authors:  Valerie J Ehlers; Getahun S Aragaw
Journal:  Afr J Prim Health Care Fam Med       Date:  2014-08-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.